Medical device briefs
Thursday, 05 February, 2009
Nanosonics has been granted approval by the Therapeutic Goods Administration to market its Trophon EPR device.
The device disinfects ultrasound probes and is aimed at hospitals, specialists and radiology clinics.
It has received earlier approval in the EU, Canada and New Zealand and is awaiting approval from the US FDA.
Polartechnics has signed agreements in Thailand, the Philippines, Indonesia and Sri Lanka for its TruScreen and CerviScreen diagnostics.
TruScreen is a point-of-care test for HPV while CerviScreen is a self-administered test.
Listed lab consumables company Fluorotechnics has changed its trading name to Gel Company. Its ASX name will remain the same.
Lead exposure linked to memory problems, even decades later
Historic lead levels from the era of leaded petrol may be contributing to cognitive issues 50...
New vulnerability found in the aging brain
An international research team has discovered that in the aging brain, certain proteins are lost...
Genetic weak spot found in hard-to-treat cancers
Research shows that blocking minor splicing can markedly slow tumour growth in liver, lung and...
